These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 2542151)
1. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Satoh F; Umemura S; Osamura RY Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771 [TBL] [Abstract][Full Text] [Related]
4. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid. Collette J; Hendrick JC; Jaspar JM; Franchimont P Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713 [TBL] [Abstract][Full Text] [Related]
5. Kappa casein, lactalbumin and GCDFP 70 localization in human breast carcinomas: an immunohistochemical study using the avidin-biotin-peroxidase complex method. Charpin C; Martin PM; Lachard A; Jacquemier J; Lavaut MN; Andonian C; Pourreau-Schneider N; Toga M Med Oncol Tumor Pharmacother; 1985; 2(2):103-12. PubMed ID: 2997552 [TBL] [Abstract][Full Text] [Related]
6. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521 [TBL] [Abstract][Full Text] [Related]
7. Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors. Mazoujian G; Bodian C; Haagensen DE; Haagensen CD Cancer; 1989 Jun; 63(11):2156-61. PubMed ID: 2655863 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. Ormsby AH; Snow JL; Su WP; Goellner JR J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013 [TBL] [Abstract][Full Text] [Related]
9. Alpha-lactalbumin and GCDFP-15 as breast tumor markers (an opportunity to study breast tumors functionally). Collette J; Van Cauwenberge JR; Le Doussal V; Serilas M; Hustin J; Carlisi A; Dejardin L; Franchimont P Int J Rad Appl Instrum B; 1987; 14(4):385-95. PubMed ID: 3654256 [No Abstract] [Full Text] [Related]
10. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Mazoujian G; Pinkus GS; Davis S; Haagensen DE Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702 [TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Ansai S; Koseki S; Hozumi Y; Kondo S Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer. Nonami Y; Hisa S; Yamamoto A; Sasaguri S; Kiyoku H; Kurumaya H J Cardiovasc Surg (Torino); 2001 Aug; 42(4):561-4. PubMed ID: 11455297 [TBL] [Abstract][Full Text] [Related]
13. Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Fiel MI; Cernaianu G; Burstein DE; Batheja N Acta Cytol; 1996; 40(4):637-41. PubMed ID: 8693878 [TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum. Mazoujian G; Parish TH; Haagensen DE J Histochem Cytochem; 1988 Apr; 36(4):377-82. PubMed ID: 3279111 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors. Mazoujian G Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin. Mazoujian G; Margolis R Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984 [TBL] [Abstract][Full Text] [Related]
17. Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Takeda Y; Tsuta K; Shibuki Y; Hoshino T; Tochigi N; Maeshima AM; Asamura H; Sasajima Y; Ito T; Matsuno Y Arch Pathol Lab Med; 2008 Feb; 132(2):239-43. PubMed ID: 18251583 [TBL] [Abstract][Full Text] [Related]
18. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy. Kohler S; Smoller BR Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens. Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055 [TBL] [Abstract][Full Text] [Related]
20. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Monteagudo C; Merino MJ; LaPorte N; Neumann RD Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]